Dr. Lynn A. Cornelius, MD

Dr. Cornelius practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Cornelius' NPI, 1922025451, was assigned on July 17, 2006. Dr. Cornelius graduated from University of Missouri School of Medicine in 1984. Dr. Cornelius holds Missouri license R7F40.

Dr. Cornelius' primary practice is Washington University School of Medicine, at 4921 Parkview Pl, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 747-5192.

Dr. Cornelius' primary practice is Washington University School of Medicine in Saint Louis, Missouri. Dr. Cornelius is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Cornelius to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cornelius practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Cornelius' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Cornelius is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Cornelius' licenses on file in 2 states: Missouri and Georgia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, joint cyst, minor injury to a limb and psoriasis among the conditions Dr. Cornelius treats.

CMS data shows 1,127 Medicare services from Dr. Cornelius across 10 procedure codes in 2024, for 321 Medicare patients. Medicare paid $51,988 for them. Every service was in an office.

CMS counts 321 Medicare patients who saw Dr. Cornelius in 2024. The largest group is 65 to 74, with 149 patients. 74% of them have high cholesterol, and 69% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cornelius' median patient age at 66, with 56% women.

In 2024, Dr. Cornelius wrote 495 Medicare Part D claims for 170 patients. 95% of them were for generic drugs. CMS names the drug for 409 of them, across 11 drugs with 11 or more claims each, at $9,848 in total drug cost. In 2023, CMS named 341 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Cornelius for performance year 2024, reported as part of a group. Dr. Cornelius accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 243 procedures of removal of skin lesions by Dr. Cornelius, more than 80% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 90 papers to Dr. Cornelius, published from 2009 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Skin Neoplasms, Melanoma and Cells, Cultured. Dr. Cornelius has published most often in J Invest Dermatol. Dr. Cornelius' most frequent co-authors are Gerald Philip Linette, MD, Ilana Shaina Rosman, MD and George Ansstas, MD.

Dmand AI links Dr. Cornelius to 3 clinical trials, 2 of them phase 1 studies. Conditions studied include Melanoma and Nevi and Melanomas.

CMS Open Payments shows 2 general payments to Dr. Cornelius from 2 drug and device companies from 2021 to 2023. Consulting fees make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $9,500. It also lists 1 research payment totaling $8,750 in 2020.

Dmand AI lists 4 awards for Dr. Cornelius, most recently AAD Fellow in 2012.

Dr. Cornelius graduated from University of Missouri School of Medicine in 1984. Dr. Cornelius is a member of AAD, Association of Professors in Dermatology and Society of Investigative Dermatology.

Dr. Cornelius is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.